Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Lucid Diagnostics Inc. reported revenue of $5M, up 8.3% year over year. Operating margin was -1054.8% and net margin -1232.7%, on a free-cash-flow margin of -992.0% with capital expenditure at 4.2% of revenue. Every figure is computed directly from LUCD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $5M | -1054.8% | -1232.7% |
| FY2024 | $4M | -1059.6% | -1047.6% |
| FY2023 | $2M | -1996.8% | -2169.1% |
| FY2022 | $0M | -14920.7% | -14899.5% |
| FY2021 | $1M | -5483.8% | -5615.6% |
How does LUCD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.